{"SPADE_UN_21629": {"Sequence Information": {"Peptide Name": "HB35, FLAK26 AMD", "Sequence": "FAKKLAKLAKKLAKLAL", "Sequence Length": 17, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antimicrobial peptide therapeutics for cystic fibrosis.", "Pubmed ID": "15980369", "Reference": "Antimicrob Agents Chemother. 2005;49:2921-2927", "Author": "Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15980369"}, {"Title": "Designing Anticancer Peptides by Constructive Machine Learning.", "Pubmed ID": "29679519", "Reference": "ChemMedChem. 2018;13:1300-1302", "Author": "Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29679519"}, {"Title": "Short bioactive peptides", "Pubmed ID": "", "Reference": "PATENT US 6875744B2. 2005;:", "Author": "Owen DR, Kenner LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}], "Mass": 1855.4, "PI": 10.7, "Net Charge": 6, "Hydrophobicity": 0.44, "Frequent Amino Acids": "KAL", "Absent Amino Acids": "CDEGHIMNOPQRSTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_21629", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06635", "Similarity": 1.0, "Sequence": "FAKKLAKKLAKLAL"}, {"SPADE_ID": "SPADE_N_06647", "Similarity": 1.0, "Sequence": "FAKKLAKLAKKL"}, {"SPADE_ID": "SPADE_N_06651", "Similarity": 1.0, "Sequence": "FAKKLAKLAKKLAKLALAL"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=112.5 µM,Human fibroblasts WI-38:LD50=8 µg/ml,Human leukocytes:LD50=64 µg/ml", "Target Organism": "Escherichia coli UB1005(MIC=2µg/ml),Salmonella enterica serovar Typhimurium(MIC=4µg/ml),Pseudomonas aeruginosa PAO1(MIC=4µg/ml),Pseudomonas aeruginosa M76(MIC=2µg/ml),Pseudomonas aeruginosa M917(MIC=8µg/ml),Pseudomonas aeruginosa M1251(MIC=2µg/ml),Pseudomonas aeruginosa M1426(MIC=4µg/ml),Pseudomonas aeruginosa R70(MIC=2µg/ml),Staphylococcus aureus(MIC=8µg/ml),Candida albicans(MIC=32µg/ml),Pseudomonas stutzeri(MIC=4µg/ml),Pseudomonas fluorescens(MIC=8µg/ml),Ralstonia pickettii(MIC=4µg/ml),Stenotrophomonas maltophilia(MIC=2µg/ml),Achromobacter xylosoxidans(MIC=16µg/ml),Human breast adenocarcinoma MCF-7(EC50=5µM),Staphylococcus aureus ATCC 6538(MIC=5µg/ml),Pseudomonas aeruginosa ATCC 9027(MBC=200µg/ml),Saccharomyces cerevisiae(MFC=25µg/ml),Escherichia coli ATCC 25922(MBC=8µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=8µg/ml),Staphylococcus aureus ATCC 25923(MBC=10µg/ml),Candida albicans ATCC 10231(MFC=>40µg/ml),Human colon adenocarcinoma SW480(LD50=14µg/ml),Human melanoma BMKC(LD50=7µg/ml),Human lung carcinoma H1299(LD50=15µg/ml),Human cervical carcinoma HeLa S3(LD50=27µg/ml),Human prostate adenocarcinoma PC-3(LD50=5µg/ml)"}}}